Journal article

Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate

N Murphy, M Diviney, J Szer, P Bardy, A Grigg, R Hoyt, B King, L MacGregor, R Holdsworth, J McCluskey, BD Tait

Bone Marrow Transplantation | NATURE PUBLISHING GROUP | Published : 2006

DOI: 10.1038/sj.bmt.1705319

Citation metrics

31Web of Science
34Scopus

Keywords

Female
Hyperhomocysteinemia
Transplantation, Homologous
Transplantation Conditioning
Bone-Marrow-Transplantation
Science & Technology
Male
Dna
Tissue Donors
Humans
Genotype
Gene
C677t Polymorphism
Models, Statistical
Polymerase Chain Reaction
Stem Cell Transplantation
Folate Status
Polymorphism, Restriction Fragment Length
Life Sciences & Biomedicine
Transplantation
Hematology
Graft Vs Host Disease
Hematopoietic Stem Cell Transplantation
Proportional Hazards Models
T-Cells
Treatment Outcome
Methotrexate
Middle Aged
Polymorphism
Adult
Polymorphism, Single Nucleotide
Multivariate Analysis
Biophysics
Folic Acid
Time Factors
Chronic Myelogenous Leukemia
Cohort Studies
Transplant
Mthfr Gene
Common Mutation
Rheumatoid-Arthritis
Oncology
Mutation
Methylenetetrahydrofolate Reductase (nadph2)
Gvhd
Immunology
Adolescent
Aged
Stem Cells
Risk-Factor